This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Dermatology  • Dermatologic Procedures  • Phototherapy  • Dermatology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Onset of Psoriasis During Treatment With TNF- Antagonists: A Report of 3 Cases

Ravi Ubriani, MD; Abby S. Van Voorhees, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Human recombinant soluble tumor necrosis factor (TNF) receptors (etanercept) and monoclonal antibodies to TNF- (infliximab and adalimumab) have been used successfully to treat a wide range of inflammatory conditions, including psoriasis. We report 1 case of plaque-type psoriasis and 2 cases of pustular psoriasis that developed in patients with no history of psoriasis who were being treated with TNF- antagonists.

Report of Cases

Case 1

A 65-year-old woman with a history of rheumatoid arthritis that had been treated for 4 years with infliximab and was well controlled with maintenance therapy (3 mg/kg every 8 weeks) was seen with a 7-month history of spreading erythematous plaques suggestive of psoriasis or a drug eruption (Figure 1). These plaques began on her legs and then progressed to involve her trunk and extremities. She had no personal or family history of psoriasis and denied any preceding upper respiratory infection.

Figure appears in full text version. . . . [Full Text of this Article]

Case 2

Case 3

Comment

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Psoriasis and Pustular Dermatitis Triggered by TNF- Inhibitors in Patients With Rheumatologic Conditions
Gillian C. de Gannes, Mehran Ghoreishi, Janet Pope, Anthony Russell, David Bell, Stewart Adams, Kamran Shojania, Magdalena Martinka, and Jan P. Dutz
Arch Dermatol. 2007;143(2):223-231.
ABSTRACT | FULL TEXT  

The Yin and Yang of TNF- Inhibition
David F. Fiorentino
Arch Dermatol. 2007;143(2):233-236.
EXTRACT | FULL TEXT  

National Psoriasis Foundation Clinical Consensus on Disease Severity
David M. Pariser, Jerry Bagel, Joel M. Gelfand, Neil J. Korman, Christopher T. Ritchlin, Bruce E. Strober, Abby S. Van Voorhees, Melodie Young, Sheila Rittenberg, Mark G. Lebwohl, Elizabeth J. Horn, and for the National Psoriasis Foundation
Arch Dermatol. 2007;143(2):239-242.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor {alpha} therapy: results from the British Society for Rheumatology Biologics Register
Harrison et al.
Ann Rheum Dis 2009;68:209-215.
ABSTRACT | FULL TEXT  

Infliximab-Induced Palmoplantar Pustulosis in a Patient With Crohn Disease
Sladden et al.
Arch Dermatol 2007;143:1449-1449.
FULL TEXT  

Psoriasis Fights Back
Journal Watch Dermatology 2007;2007:1-1.
FULL TEXT  

The Yin and Yang of TNF-{alpha} Inhibition
Fiorentino
Arch Dermatol 2007;143:233-236.
FULL TEXT